| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | nuclear retinoic acid receptor binding | 1.04e-07 | 55 | 139 | 7 | GO:0042974 | |
| GeneOntologyMolecularFunction | ubiquitin-like ligase-substrate adaptor activity | 1.67e-06 | 82 | 139 | 7 | GO:1990756 | |
| GeneOntologyMolecularFunction | enzyme-substrate adaptor activity | 4.51e-06 | 95 | 139 | 7 | GO:0140767 | |
| GeneOntologyMolecularFunction | heparin binding | 8.14e-06 | 192 | 139 | 9 | GO:0008201 | |
| GeneOntologyMolecularFunction | glycosaminoglycan binding | 1.87e-05 | 268 | 139 | 10 | GO:0005539 | |
| GeneOntologyMolecularFunction | complement component C3b receptor activity | 4.81e-05 | 2 | 139 | 2 | GO:0004877 | |
| GeneOntologyMolecularFunction | complement component C4b receptor activity | 4.81e-05 | 2 | 139 | 2 | GO:0001861 | |
| GeneOntologyMolecularFunction | complement component C4b binding | 1.44e-04 | 3 | 139 | 2 | GO:0001855 | |
| GeneOntologyMolecularFunction | group III metabotropic glutamate receptor activity | 2.86e-04 | 4 | 139 | 2 | GO:0001642 | |
| GeneOntologyMolecularFunction | nuclear receptor binding | 3.41e-04 | 187 | 139 | 7 | GO:0016922 | |
| GeneOntologyMolecularFunction | sulfur compound binding | 4.42e-04 | 323 | 139 | 9 | GO:1901681 | |
| GeneOntologyMolecularFunction | N-acetylglucosamine 6-O-sulfotransferase activity | 9.87e-04 | 7 | 139 | 2 | GO:0001517 | |
| GeneOntologyMolecularFunction | opsonin receptor activity | 1.31e-03 | 8 | 139 | 2 | GO:0001847 | |
| GeneOntologyMolecularFunction | zinc ion binding | TRIM46 EPRS1 ADAMTS3 TRIM26 ZFAND2B SIAH1 CXXC1 SIRT3 TRIM10 ZNF276 ADAMTS9 NFXL1 COL25A1-DT KNG1 ZMYM6 | 1.39e-03 | 891 | 139 | 15 | GO:0008270 |
| GeneOntologyMolecularFunction | metalloendopeptidase activity | 1.53e-03 | 120 | 139 | 5 | GO:0004222 | |
| GeneOntologyMolecularFunction | G protein-coupled glutamate receptor activity | 1.68e-03 | 9 | 139 | 2 | GO:0098988 | |
| GeneOntologyMolecularFunction | adenylate cyclase inhibiting G protein-coupled glutamate receptor activity | 1.68e-03 | 9 | 139 | 2 | GO:0001640 | |
| GeneOntologyMolecularFunction | histone H3K14 acetyltransferase activity | 1.68e-03 | 9 | 139 | 2 | GO:0036408 | |
| GeneOntologyMolecularFunction | serine-type endopeptidase activity | 2.16e-03 | 190 | 139 | 6 | GO:0004252 | |
| GeneOntologyBiologicalProcess | oocyte development | PRAMEF7 PDE3A PRAMEF12 PRAMEF8 PRAMEF1 PRAMEF2 PRAMEF13 PRAMEF14 | 3.18e-07 | 99 | 137 | 8 | GO:0048599 |
| GeneOntologyBiologicalProcess | oocyte differentiation | PRAMEF7 PDE3A PRAMEF12 PRAMEF8 PRAMEF1 PRAMEF2 PRAMEF13 PRAMEF14 | 4.31e-07 | 103 | 137 | 8 | GO:0009994 |
| GeneOntologyBiologicalProcess | blastocyst formation | 8.72e-07 | 78 | 137 | 7 | GO:0001825 | |
| GeneOntologyBiologicalProcess | in utero embryonic development | PRAMEF7 ADAMTS3 NBN PRAMEF12 PRAMEF8 PRAMEF1 PRAMEF2 CR1 CR1L PRAMEF13 JAG2 FZD5 PRAMEF14 ZNF335 CHRD HECTD1 | 2.26e-06 | 596 | 137 | 16 | GO:0001701 |
| GeneOntologyBiologicalProcess | somatic stem cell population maintenance | 7.80e-06 | 108 | 137 | 7 | GO:0035019 | |
| GeneOntologyBiologicalProcess | oogenesis | PRAMEF7 PDE3A PRAMEF12 PRAMEF8 PRAMEF1 PRAMEF2 PRAMEF13 PRAMEF14 | 9.80e-06 | 156 | 137 | 8 | GO:0048477 |
| GeneOntologyBiologicalProcess | complement activation, classical pathway | 1.06e-05 | 44 | 137 | 5 | GO:0006958 | |
| GeneOntologyBiologicalProcess | female gamete generation | PRAMEF7 PDE3A MCM8 PRAMEF12 PRAMEF8 PRAMEF1 PRAMEF2 PRAMEF13 PRAMEF14 | 1.86e-05 | 223 | 137 | 9 | GO:0007292 |
| GeneOntologyBiologicalProcess | ERK1 and ERK2 cascade | PRAMEF7 SPRY3 ERBB2 PRAMEF12 PRAMEF8 PRAMEF1 PRAMEF2 PRAMEF13 SIRT3 RGS14 KARS1 PRAMEF14 | 2.33e-05 | 418 | 137 | 12 | GO:0070371 |
| GeneOntologyBiologicalProcess | blastocyst development | PRAMEF7 NBN PRAMEF12 PRAMEF8 PRAMEF1 PRAMEF2 PRAMEF13 PRAMEF14 | 2.65e-05 | 179 | 137 | 8 | GO:0001824 |
| GeneOntologyBiologicalProcess | chordate embryonic development | PRAMEF7 LIAS ADAMTS3 NBN PRAMEF12 PRAMEF8 PRAMEF1 PRAMEF2 CR1 CR1L PRAMEF13 JAG2 FZD5 PRAMEF14 ZNF335 CHRD HECTD1 CRB2 | 3.19e-05 | 906 | 137 | 18 | GO:0043009 |
| GeneOntologyBiologicalProcess | embryo development ending in birth or egg hatching | PRAMEF7 LIAS ADAMTS3 NBN PRAMEF12 PRAMEF8 PRAMEF1 PRAMEF2 CR1 CR1L PRAMEF13 JAG2 FZD5 PRAMEF14 ZNF335 CHRD HECTD1 CRB2 | 4.42e-05 | 929 | 137 | 18 | GO:0009792 |
| GeneOntologyBiologicalProcess | regulation of ERK1 and ERK2 cascade | PRAMEF7 SPRY3 ERBB2 PRAMEF12 PRAMEF8 PRAMEF1 PRAMEF2 PRAMEF13 SIRT3 RGS14 PRAMEF14 | 5.38e-05 | 385 | 137 | 11 | GO:0070372 |
| GeneOntologyBiologicalProcess | humoral immune response mediated by circulating immunoglobulin | 5.74e-05 | 62 | 137 | 5 | GO:0002455 | |
| GeneOntologyBiologicalProcess | complement activation | 1.03e-04 | 70 | 137 | 5 | GO:0006956 | |
| GeneOntologyBiologicalProcess | anatomical structure formation involved in morphogenesis | PRAMEF7 CACNA1S LIAS ERBB2 THSD7A ADGRB1 PRAMEF12 APOH PRAMEF8 PRAMEF1 PRAMEF2 PRAMEF13 CRB1 SRPX2 ADAMTS9 FZD5 PRAMEF14 TNFRSF13C MIOS CHRD HECTD1 CRB2 WDR72 | 1.15e-04 | 1483 | 137 | 23 | GO:0048646 |
| GeneOntologyBiologicalProcess | negative regulation of developmental process | TRIM46 PRAMEF7 SPRY3 ERBB2 ADGRB1 NBN PRAMEF12 APOH PRAMEF8 PRAMEF1 PRAMEF2 CR1 FAS PRAMEF13 ADAMTS9 PRAMEF14 CHRD LTF MUL1 GLIS1 | 1.63e-04 | 1220 | 137 | 20 | GO:0051093 |
| GeneOntologyBiologicalProcess | stem cell population maintenance | PRAMEF7 PRAMEF12 PRAMEF8 PRAMEF1 PRAMEF2 PRAMEF13 PRAMEF14 PHF10 | 1.89e-04 | 237 | 137 | 8 | GO:0019827 |
| GeneOntologyBiologicalProcess | extracellular matrix organization | KLK7 COL13A1 ADAMTS3 TMPRSS6 ADAMTSL3 NOXO1 ADAMTS9 ADAMTS17 LTBP4 WDR72 | 2.17e-04 | 377 | 137 | 10 | GO:0030198 |
| GeneOntologyBiologicalProcess | maintenance of cell number | PRAMEF7 PRAMEF12 PRAMEF8 PRAMEF1 PRAMEF2 PRAMEF13 PRAMEF14 PHF10 | 2.18e-04 | 242 | 137 | 8 | GO:0098727 |
| GeneOntologyBiologicalProcess | extracellular structure organization | KLK7 COL13A1 ADAMTS3 TMPRSS6 ADAMTSL3 NOXO1 ADAMTS9 ADAMTS17 LTBP4 WDR72 | 2.21e-04 | 378 | 137 | 10 | GO:0043062 |
| GeneOntologyBiologicalProcess | external encapsulating structure organization | KLK7 COL13A1 ADAMTS3 TMPRSS6 ADAMTSL3 NOXO1 ADAMTS9 ADAMTS17 LTBP4 WDR72 | 2.26e-04 | 379 | 137 | 10 | GO:0045229 |
| GeneOntologyBiologicalProcess | telomeric 3' overhang formation | 2.60e-04 | 4 | 137 | 2 | GO:0031860 | |
| GeneOntologyBiologicalProcess | regulation of MAPK cascade | PRAMEF7 SPRY3 ERBB2 DRD4 PRAMEF12 PRAMEF8 PRAMEF1 PRAMEF2 GRM4 FAS PRAMEF13 SIRT3 RGS14 FZD5 PRAMEF14 | 3.45e-04 | 815 | 137 | 15 | GO:0043408 |
| GeneOntologyBiologicalProcess | MAPK cascade | PRAMEF7 SPRY3 ERBB2 DRD4 PRAMEF12 PRAMEF8 PRAMEF1 PRAMEF2 GRM4 FAS PRAMEF13 SIRT3 RGS14 KARS1 FZD5 PRAMEF14 | 4.58e-04 | 930 | 137 | 16 | GO:0000165 |
| GeneOntologyCellularComponent | Cul2-RING ubiquitin ligase complex | 2.49e-08 | 47 | 139 | 7 | GO:0031462 | |
| GeneOntologyCellularComponent | cullin-RING ubiquitin ligase complex | PRAMEF7 SIAH1 PRAMEF12 PRAMEF8 PRAMEF1 PRAMEF2 PRAMEF13 PRAMEF14 | 8.86e-05 | 212 | 139 | 8 | GO:0031461 |
| GeneOntologyCellularComponent | CAF-1 complex | 1.31e-04 | 3 | 139 | 2 | GO:0033186 | |
| GeneOntologyCellularComponent | subapical complex | 4.33e-04 | 5 | 139 | 2 | GO:0035003 | |
| GeneOntologyCellularComponent | acrosomal vesicle | 4.64e-04 | 206 | 139 | 7 | GO:0001669 | |
| GeneOntologyCellularComponent | MOZ/MORF histone acetyltransferase complex | 9.02e-04 | 7 | 139 | 2 | GO:0070776 | |
| MousePheno | abnormal spermatogonia proliferation | 1.08e-07 | 47 | 116 | 7 | MP:0002685 | |
| MousePheno | increased circulating amylase level | PRAMEF7 CHAF1B BACH2 PRAMEF12 PRAMEF8 PRAMEF1 PRAMEF2 PRAMEF13 PRAMEF14 | 6.15e-07 | 119 | 116 | 9 | MP:0008806 |
| MousePheno | abnormal jejunum morphology | 1.02e-06 | 41 | 116 | 6 | MP:0004002 | |
| MousePheno | abnormal circulating amylase level | PRAMEF7 CHAF1B BACH2 PRAMEF12 PRAMEF8 PRAMEF1 PRAMEF2 PRAMEF13 PRAMEF14 | 5.87e-06 | 156 | 116 | 9 | MP:0008804 |
| MousePheno | abnormal duodenum morphology | 1.45e-05 | 64 | 116 | 6 | MP:0003271 | |
| MousePheno | increased kidney weight | PRAMEF7 PRAMEF12 PRAMEF8 PRAMEF1 PRAMEF2 PRAMEF13 WDHD1 PRAMEF14 | 2.73e-05 | 145 | 116 | 8 | MP:0003917 |
| MousePheno | enlarged urinary bladder | 5.00e-05 | 116 | 116 | 7 | MP:0011874 | |
| MousePheno | absent gametes | PRAMEF7 MCM8 NBN SIAH1 PRAMEF12 PRAMEF8 PRAMEF1 PRAMEF2 PRAMEF13 PRAMEF14 | 5.29e-05 | 256 | 116 | 10 | MP:0001117 |
| MousePheno | abnormal male germ cell apoptosis | PRAMEF7 MCM8 PRAMEF12 PRAMEF8 PRAMEF1 PRAMEF2 PRAMEF13 PSME4 PRAMEF14 | 1.52e-04 | 236 | 116 | 9 | MP:0008280 |
| MousePheno | abnormal cecum morphology | 1.72e-04 | 99 | 116 | 6 | MP:0000494 | |
| MousePheno | increased male germ cell apoptosis | PRAMEF7 PRAMEF12 PRAMEF8 PRAMEF1 PRAMEF2 PRAMEF13 PSME4 PRAMEF14 | 1.76e-04 | 189 | 116 | 8 | MP:0014052 |
| MousePheno | azoospermia | PRAMEF7 MCM8 SIAH1 PRAMEF12 PRAMEF8 PRAMEF1 PRAMEF2 PRAMEF13 PRAMEF14 | 1.95e-04 | 244 | 116 | 9 | MP:0005159 |
| MousePheno | abnormal male germ cell physiology | PRAMEF7 MCM8 PRAMEF12 PRAMEF8 PRAMEF1 PRAMEF2 PRAMEF13 PSME4 PRAMEF14 | 1.95e-04 | 244 | 116 | 9 | MP:0020362 |
| Domain | TSP1 | THSD7A ADAMTS3 ADGRB1 RSPO4 THSD7B ADAMTSL3 CCN5 CILP2 ADAMTS9 ADAMTS17 | 4.11e-11 | 65 | 137 | 10 | SM00209 |
| Domain | TSP1_rpt | THSD7A ADAMTS3 ADGRB1 RSPO4 THSD7B ADAMTSL3 CCN5 CILP2 ADAMTS9 ADAMTS17 | 4.11e-11 | 65 | 137 | 10 | IPR000884 |
| Domain | TSP1 | THSD7A ADAMTS3 ADGRB1 RSPO4 THSD7B ADAMTSL3 CCN5 CILP2 ADAMTS9 ADAMTS17 | 4.11e-11 | 65 | 137 | 10 | PS50092 |
| Domain | TSP_1 | THSD7A ADAMTS3 ADGRB1 THSD7B ADAMTSL3 CCN5 CILP2 ADAMTS9 ADAMTS17 | 7.98e-10 | 63 | 137 | 9 | PF00090 |
| Domain | PRAME_family | 3.50e-09 | 19 | 137 | 6 | IPR026271 | |
| Domain | Sushi | 9.95e-08 | 52 | 137 | 7 | PF00084 | |
| Domain | CCP | 1.30e-07 | 54 | 137 | 7 | SM00032 | |
| Domain | SUSHI | 1.68e-07 | 56 | 137 | 7 | PS50923 | |
| Domain | Sushi_SCR_CCP_dom | 1.91e-07 | 57 | 137 | 7 | IPR000436 | |
| Domain | EGF_Ca-bd_CS | 7.26e-06 | 97 | 137 | 7 | IPR018097 | |
| Domain | EGF_CA | 8.32e-06 | 99 | 137 | 7 | PS01187 | |
| Domain | ASX_HYDROXYL | 8.89e-06 | 100 | 137 | 7 | PS00010 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 1.30e-05 | 106 | 137 | 7 | IPR000152 | |
| Domain | Growth_fac_rcpt_ | 1.99e-05 | 156 | 137 | 8 | IPR009030 | |
| Domain | Peptidase_M12B_ADAM-TS | 2.63e-05 | 24 | 137 | 4 | IPR013273 | |
| Domain | EGF_CA | 3.25e-05 | 122 | 137 | 7 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 3.61e-05 | 124 | 137 | 7 | IPR001881 | |
| Domain | VWFC_1 | 1.36e-04 | 36 | 137 | 4 | PS01208 | |
| Domain | EGF_2 | 1.50e-04 | 265 | 137 | 9 | PS01186 | |
| Domain | VWFC_2 | 1.69e-04 | 38 | 137 | 4 | PS50184 | |
| Domain | VWC | 1.69e-04 | 38 | 137 | 4 | SM00214 | |
| Domain | VWF_dom | 2.50e-04 | 42 | 137 | 4 | IPR001007 | |
| Domain | FAM47 | 3.17e-04 | 4 | 137 | 2 | PF14642 | |
| Domain | Pept_S1A_C1r/C1S/mannan-bd | 3.17e-04 | 4 | 137 | 2 | IPR024175 | |
| Domain | FAM47 | 3.17e-04 | 4 | 137 | 2 | IPR032743 | |
| Domain | PLAC | 3.43e-04 | 19 | 137 | 3 | PS50900 | |
| Domain | PLAC | 3.43e-04 | 19 | 137 | 3 | IPR010909 | |
| Domain | EGF_3 | 3.46e-04 | 235 | 137 | 8 | PS50026 | |
| Domain | EGF_CA | 4.27e-04 | 86 | 137 | 5 | PF07645 | |
| Domain | EGF-like_dom | 5.09e-04 | 249 | 137 | 8 | IPR000742 | |
| Domain | TRYPSIN_SER | 5.26e-04 | 90 | 137 | 5 | IPR033116 | |
| Domain | EGF_1 | 5.95e-04 | 255 | 137 | 8 | PS00022 | |
| Domain | ADAM_spacer1 | 6.14e-04 | 23 | 137 | 3 | IPR010294 | |
| Domain | ADAM_spacer1 | 6.14e-04 | 23 | 137 | 3 | PF05986 | |
| Domain | EGF-like_CS | 6.92e-04 | 261 | 137 | 8 | IPR013032 | |
| Domain | TRYPSIN_HIS | 9.72e-04 | 103 | 137 | 5 | IPR018114 | |
| Domain | TB | 1.09e-03 | 7 | 137 | 2 | PF00683 | |
| Domain | Carbohydrate_sulfotransferase | 1.09e-03 | 7 | 137 | 2 | IPR016469 | |
| Domain | TRYPSIN_SER | 1.11e-03 | 106 | 137 | 5 | PS00135 | |
| Domain | hEGF | 1.11e-03 | 28 | 137 | 3 | PF12661 | |
| Domain | VWC | 1.11e-03 | 28 | 137 | 3 | PF00093 | |
| Domain | TRYPSIN_HIS | 1.15e-03 | 107 | 137 | 5 | PS00134 | |
| Domain | - | 1.45e-03 | 8 | 137 | 2 | 3.90.290.10 | |
| Domain | GPCR_3_mtglu_rcpt | 1.45e-03 | 8 | 137 | 2 | IPR000162 | |
| Domain | Peptidase_S1A | 1.47e-03 | 113 | 137 | 5 | IPR001314 | |
| Domain | TRYPSIN_DOM | 1.59e-03 | 115 | 137 | 5 | PS50240 | |
| Domain | Tryp_SPc | 1.71e-03 | 117 | 137 | 5 | SM00020 | |
| Domain | EGF | 1.76e-03 | 235 | 137 | 7 | SM00181 | |
| Domain | - | TRIM46 BRPF3 TRIM26 SIAH1 CXXC1 TRIM10 LONRF2 KAT6B PHF10 MUL1 | 1.77e-03 | 449 | 137 | 10 | 3.30.40.10 |
| Domain | TB_dom | 1.86e-03 | 9 | 137 | 2 | IPR017878 | |
| Domain | TB | 1.86e-03 | 9 | 137 | 2 | PS51364 | |
| Domain | Trypsin_dom | 1.99e-03 | 121 | 137 | 5 | IPR001254 | |
| Domain | Trypsin | 1.99e-03 | 121 | 137 | 5 | PF00089 | |
| Domain | Znf_RING/FYVE/PHD | TRIM46 BRPF3 TRIM26 SIAH1 CXXC1 TRIM10 LONRF2 KAT6B PHF10 MUL1 | 2.08e-03 | 459 | 137 | 10 | IPR013083 |
| Domain | Peptidase_S1_PA | 2.14e-03 | 123 | 137 | 5 | IPR009003 | |
| Domain | PHD | 2.25e-03 | 75 | 137 | 4 | PF00628 | |
| Domain | EGF | 2.37e-03 | 126 | 137 | 5 | PF00008 | |
| Domain | Znf_PHD-finger | 2.72e-03 | 79 | 137 | 4 | IPR019787 | |
| Domain | Pep_M12B_propep | 2.91e-03 | 39 | 137 | 3 | PF01562 | |
| Domain | Peptidase_M12B_N | 2.91e-03 | 39 | 137 | 3 | IPR002870 | |
| Domain | DISINTEGRIN_1 | 3.13e-03 | 40 | 137 | 3 | PS00427 | |
| Domain | Reprolysin | 3.13e-03 | 40 | 137 | 3 | PF01421 | |
| Domain | ADAM_MEPRO | 3.13e-03 | 40 | 137 | 3 | PS50215 | |
| Domain | DISINTEGRIN_2 | 3.13e-03 | 40 | 137 | 3 | PS50214 | |
| Domain | Peptidase_M12B | 3.13e-03 | 40 | 137 | 3 | IPR001590 | |
| Domain | Disintegrin_dom | 3.36e-03 | 41 | 137 | 3 | IPR001762 | |
| Domain | NCD3G | 3.95e-03 | 13 | 137 | 2 | PF07562 | |
| Domain | GPCR_3_9-Cys_dom | 3.95e-03 | 13 | 137 | 2 | IPR011500 | |
| Domain | PHD | 4.18e-03 | 89 | 137 | 4 | SM00249 | |
| Domain | Znf_PHD | 4.52e-03 | 91 | 137 | 4 | IPR001965 | |
| Domain | PLAC | 4.59e-03 | 14 | 137 | 2 | PF08686 | |
| Domain | GPCR_3_CS | 4.59e-03 | 14 | 137 | 2 | IPR017979 | |
| Domain | ZF_PHD_2 | 5.27e-03 | 95 | 137 | 4 | PS50016 | |
| Domain | ZF_PHD_1 | 5.47e-03 | 96 | 137 | 4 | PS01359 | |
| Domain | ZF_RING_1 | 5.71e-03 | 291 | 137 | 7 | PS00518 | |
| Domain | CUB | 5.88e-03 | 50 | 137 | 3 | SM00042 | |
| Domain | VWF_type-D | 5.99e-03 | 16 | 137 | 2 | IPR001846 | |
| Domain | VWFD | 5.99e-03 | 16 | 137 | 2 | PS51233 | |
| Domain | VWD | 5.99e-03 | 16 | 137 | 2 | SM00216 | |
| Domain | VWD | 5.99e-03 | 16 | 137 | 2 | PF00094 | |
| Domain | ZF_RING_2 | 6.48e-03 | 298 | 137 | 7 | PS50089 | |
| Domain | - | 6.56e-03 | 52 | 137 | 3 | 2.60.120.290 | |
| Domain | CUB | 6.92e-03 | 53 | 137 | 3 | PS01180 | |
| Domain | WD40_repeat_CS | 7.24e-03 | 164 | 137 | 5 | IPR019775 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 2.96e-07 | 39 | 100 | 6 | M27417 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 2.96e-07 | 39 | 100 | 6 | MM15165 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 8.40e-06 | 68 | 100 | 6 | M27303 | |
| Pathway | WP_COMPLEMENT_SYSTEM_IN_NEURONAL_DEVELOPMENT_AND_PLASTICITY | 1.00e-05 | 106 | 100 | 7 | M42535 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 1.21e-05 | 109 | 100 | 7 | MM15164 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 1.36e-05 | 111 | 100 | 7 | M27416 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CLASSICAL_PATHWAY_OF_COMPLEMENT_CASCADE_C4_C2_TO_C3_CONVERTASE_FORMATION | 1.89e-05 | 8 | 100 | 3 | M47872 | |
| Pathway | WP_COMPLEMENT_AND_COAGULATION_CASCADES | 5.52e-05 | 58 | 100 | 5 | M39649 | |
| Pathway | WP_DENGUE2_INTERACTIONS_WITH_COMPLEMENT_AND_COAGULATION_CASCADES | 6.00e-05 | 59 | 100 | 5 | M48343 | |
| Pathway | BIOCARTA_CLASSIC_PATHWAY | 7.27e-05 | 12 | 100 | 3 | MM1368 | |
| Pathway | KEGG_COMPLEMENT_AND_COAGULATION_CASCADES | 1.27e-04 | 69 | 100 | 5 | M16894 | |
| Pathway | BIOCARTA_CLASSIC_PATHWAY | 1.48e-04 | 15 | 100 | 3 | M7146 | |
| Pathway | WP_COMPLEMENT_ACTIVATION_CLASSICAL_PATHWAY | 2.19e-04 | 17 | 100 | 3 | MM15944 | |
| Pathway | BIOCARTA_COMP_PATHWAY | 2.19e-04 | 17 | 100 | 3 | MM1369 | |
| Pathway | BIOCARTA_COMP_PATHWAY | 3.62e-04 | 20 | 100 | 3 | M917 | |
| Pathway | WP_COMPLEMENT_ACTIVATION | 4.84e-04 | 22 | 100 | 3 | M39502 | |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | 5.35e-04 | 143 | 100 | 6 | M27275 | |
| Pathway | KEGG_MEDICUS_REFERENCE_REGULATION_OF_FIBRINOLYTIC_SYSTEM_C1INH | 7.34e-04 | 6 | 100 | 2 | M47882 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_SARS_COV_2_S_TO_CLASSICAL_PATHWAY_OF_COMPLEMENT_CASCADE | 7.34e-04 | 6 | 100 | 2 | M47783 | |
| Pubmed | 4.99e-13 | 18 | 142 | 7 | 23894331 | ||
| Pubmed | Oogenesin is a novel mouse protein expressed in oocytes and early cleavage-stage embryos. | 4.99e-13 | 18 | 142 | 7 | 12890732 | |
| Pubmed | Oocyte-specific gene Oog1 suppresses the expression of spermatogenesis-specific genes in oocytes. | 4.99e-13 | 18 | 142 | 7 | 29731491 | |
| Pubmed | 4.99e-13 | 18 | 142 | 7 | 14675769 | ||
| Pubmed | Pramel7 mediates ground-state pluripotency through proteasomal-epigenetic combined pathways. | 7.88e-13 | 19 | 142 | 7 | 28604677 | |
| Pubmed | 1.21e-12 | 20 | 142 | 7 | 26694250 | ||
| Pubmed | 1.21e-12 | 20 | 142 | 7 | 16580637 | ||
| Pubmed | Pramel7 mediates LIF/STAT3-dependent self-renewal in embryonic stem cells. | 1.21e-12 | 20 | 142 | 7 | 21425410 | |
| Pubmed | 2.64e-12 | 22 | 142 | 7 | 31729367 | ||
| Pubmed | 3.78e-12 | 23 | 142 | 7 | 19480014 | ||
| Pubmed | Incomplete reactivation of Oct4-related genes in mouse embryos cloned from somatic nuclei. | 7.36e-12 | 25 | 142 | 7 | 12620990 | |
| Pubmed | 7.36e-12 | 25 | 142 | 7 | 37451217 | ||
| Pubmed | Expression profiling in transgenic FVB/N embryonic stem cells overexpressing STAT3. | 1.00e-11 | 26 | 142 | 7 | 18500982 | |
| Pubmed | 1.80e-11 | 28 | 142 | 7 | 25089626 | ||
| Pubmed | THSD7A ADAMTS3 ADGRB1 THSD7B ADAMTSL3 CCN5 CILP2 ADAMTS9 ADAMTS17 | 2.44e-11 | 75 | 142 | 9 | 20637190 | |
| Pubmed | Thirteen Ovary-Enriched Genes Are Individually Not Essential for Female Fertility in Mice. | 3.07e-11 | 30 | 142 | 7 | 38786026 | |
| Pubmed | Differential expression of PRAMEL1, a cancer/testis antigen, during spermatogenesis in the mouse. | 4.97e-11 | 17 | 142 | 6 | 23565261 | |
| Pubmed | 4.97e-11 | 17 | 142 | 6 | 37781892 | ||
| Pubmed | LSM14B is essential for oocyte meiotic maturation by regulating maternal mRNA storage and clearance. | 5.03e-11 | 32 | 142 | 7 | 37889087 | |
| Pubmed | Pramel15 facilitates zygotic nuclear DNMT1 degradation and DNA demethylation. | 7.43e-11 | 18 | 142 | 6 | 39181896 | |
| Pubmed | 9.96e-11 | 35 | 142 | 7 | 19389355 | ||
| Pubmed | 7.63e-10 | 46 | 142 | 7 | 17287250 | ||
| Pubmed | DUX is a non-essential synchronizer of zygotic genome activation. | 1.41e-09 | 50 | 142 | 7 | 31806660 | |
| Pubmed | 6.66e-08 | 3 | 142 | 3 | 11907125 | ||
| Pubmed | PRAMEF7 THSD7A SIAH1 PRAMEF12 PRAMEF8 PRAMEF1 PRAMEF2 PRAMEF13 PRAMEF14 NFXL1 FAM47E | 1.11e-07 | 326 | 142 | 11 | 17015433 | |
| Pubmed | 1.42e-07 | 58 | 142 | 6 | 31598710 | ||
| Pubmed | 1.57e-07 | 59 | 142 | 6 | 11279525 | ||
| Pubmed | Transcriptome analysis of mouse stem cells and early embryos. | PRAMEF7 KCP PRAMEF12 PRAMEF8 PRAMEF1 PRAMEF2 MAST2 PRAMEF13 ADAMTS9 PRAMEF14 ZNF335 | 3.25e-07 | 363 | 142 | 11 | 14691545 |
| Pubmed | 6.62e-07 | 5 | 142 | 3 | 28742139 | ||
| Pubmed | Absence of CD59 exacerbates systemic autoimmunity in MRL/lpr mice. | 1.32e-06 | 6 | 142 | 3 | 23109726 | |
| Pubmed | Deterministic and stochastic allele specific gene expression in single mouse blastomeres. | PRAMEF7 PRAMEF12 PRAMEF8 PRAMEF1 PRAMEF2 PRAMEF13 JAG2 FZD5 PRAMEF14 FBLIM1 KAT6B | 1.48e-06 | 424 | 142 | 11 | 21731673 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | NPC1 ERBB2 MAST2 NPHP4 PPP1R26 JAG2 DIP2A ZNF276 PSME4 MAP1S EPOP ZNF335 OSBPL5 WDR90 HECTD1 LTBP4 ZNF687 | 2.93e-06 | 1105 | 142 | 17 | 35748872 |
| Pubmed | Mouse screen reveals multiple new genes underlying mouse and human hearing loss. | PRAMEF7 BRPF3 ADAMTS3 BACH2 ADGRB1 RSPO4 PRAMEF12 PRAMEF8 PRAMEF1 PRAMEF2 MAST2 PRAMEF13 SIRT3 DIP2A PRAMEF14 FAM47E KNG1 CRB2 | 3.37e-06 | 1242 | 142 | 18 | 30973865 |
| Pubmed | Mapping the NPHP-JBTS-MKS protein network reveals ciliopathy disease genes and pathways. | PRAMEF7 EPRS1 ACO1 KPRP PRAMEF12 PRAMEF8 PRAMEF1 PRAMEF2 NPHP4 PRAMEF13 PSME4 PRAMEF14 | 3.79e-06 | 564 | 142 | 12 | 21565611 |
| Pubmed | The DNA sequence and biological annotation of human chromosome 1. | PRAMEF7 KPRP IER5 PRAMEF12 DENND2D DCLRE1B PRAMEF8 PRAMEF1 PRAMEF2 MAST2 CRB1 PRAMEF14 FBLIM1 MUL1 ZNF687 PHTF1 | 5.25e-06 | 1031 | 142 | 16 | 16710414 |
| Pubmed | ERBB2 CHAF1B BRPF3 MCM8 RNASEH2A CHAF1A BACH2 NBN PDCD2L MAST2 GJD4 KAT6B LTBP4 PHF10 ZNF687 WDR72 | 1.40e-05 | 1116 | 142 | 16 | 31753913 | |
| Pubmed | 1.64e-05 | 130 | 142 | 6 | 12421765 | ||
| Pubmed | Crumbs proteins regulate layered retinal vascular development required for vision. | 1.66e-05 | 2 | 142 | 2 | 31718797 | |
| Pubmed | Functional identification of transcription control sequences of the mouse Crry gene. | 1.66e-05 | 2 | 142 | 2 | 8335915 | |
| Pubmed | Crry/p65, a membrane complement regulatory protein, has costimulatory properties on mouse T cells. | 1.66e-05 | 2 | 142 | 2 | 10779754 | |
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 16444293 | ||
| Pubmed | CHAF1A/B mediate silencing of unintegrated HIV-1 DNAs early in infection. | 1.66e-05 | 2 | 142 | 2 | 35074917 | |
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 1730912 | ||
| Pubmed | Assignment of the complement serine protease genes C1r and C1s to chromosome 12 region 12p13. | 1.66e-05 | 2 | 142 | 2 | 2834284 | |
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 19740350 | ||
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 9477945 | ||
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 10092586 | ||
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 27745832 | ||
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 12788922 | ||
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 1533159 | ||
| Pubmed | CAF-1 and the inheritance of chromatin states: at the crossroads of DNA replication and repair. | 1.66e-05 | 2 | 142 | 2 | 10893180 | |
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 29654651 | ||
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 34910522 | ||
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 2952719 | ||
| Pubmed | Targeted ablation of CRB1 and CRB2 in retinal progenitor cells mimics Leber congenital amaurosis. | 1.66e-05 | 2 | 142 | 2 | 24339791 | |
| Pubmed | MRL Strains Have a BAFFR Mutation without Functional Consequence. | 1.66e-05 | 2 | 142 | 2 | 27149280 | |
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 2387866 | ||
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 12513694 | ||
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 12767833 | ||
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 17996945 | ||
| Pubmed | Unexpected development of autoimmunity in BAFF-R-mutant MRL-lpr mice. | 1.66e-05 | 2 | 142 | 2 | 17073941 | |
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 20484840 | ||
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 30956116 | ||
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 28252045 | ||
| Pubmed | CRB2 acts as a modifying factor of CRB1-related retinal dystrophies in mice. | 1.66e-05 | 2 | 142 | 2 | 24565864 | |
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 29893966 | ||
| Pubmed | C1R Mutations Trigger Constitutive Complement 1 Activation in Periodontal Ehlers-Danlos Syndrome. | 1.66e-05 | 2 | 142 | 2 | 31749804 | |
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 17674370 | ||
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 19351574 | ||
| Pubmed | A role for oxysterol-binding protein-related protein 5 in endosomal cholesterol trafficking. | 1.66e-05 | 2 | 142 | 2 | 21220512 | |
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 30076417 | ||
| Pubmed | Human CRB1 and CRB2 form homo- and heteromeric protein complexes in the retina. | 1.66e-05 | 2 | 142 | 2 | 38570189 | |
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 11687802 | ||
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 11698469 | ||
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 20592021 | ||
| Pubmed | Expression of a Crry/p65 is reduced in acute lung injury induced by extracellular histones. | 1.66e-05 | 2 | 142 | 2 | 34709768 | |
| Pubmed | The murine complement regulator Crry: new insights into the immunobiology of complement regulation. | 1.66e-05 | 2 | 142 | 2 | 11915940 | |
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 7691944 | ||
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 2911011 | ||
| Pubmed | SIRT3 regulates cellular iron metabolism and cancer growth by repressing iron regulatory protein 1. | 1.66e-05 | 2 | 142 | 2 | 24909164 | |
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 24659671 | ||
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 12902517 | ||
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 17015675 | ||
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 7600578 | ||
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 23153828 | ||
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 12973023 | ||
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 10586048 | ||
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 16301687 | ||
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 36450590 | ||
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 16301324 | ||
| Pubmed | Exercise enhancement by RGS14 disruption is mediated by brown adipose tissue. | 1.66e-05 | 2 | 142 | 2 | 36905127 | |
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 34324282 | ||
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 39284539 | ||
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 2307848 | ||
| Pubmed | Enhanced CD95-mediated apoptosis contributes to radiation hypersensitivity of NBS lymphoblasts. | 1.66e-05 | 2 | 142 | 2 | 17219051 | |
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 21380996 | ||
| Pubmed | Regional regulation of Filiform tongue papillae development by Ikkα/Irf6. | 1.85e-05 | 13 | 142 | 3 | 27302476 | |
| Pubmed | The chromatin regulator Brpf1 regulates embryo development and cell proliferation. | 2.17e-05 | 40 | 142 | 4 | 25773539 | |
| Pubmed | The FBXL5-IRP2 axis is integral to control of iron metabolism in vivo. | 3.59e-05 | 16 | 142 | 3 | 21907140 | |
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 2295627 | ||
| Cytoband | 1p36.21 | PRAMEF7 PRAMEF12 PRAMEF8 PRAMEF1 PRAMEF2 PRAMEF13 PRAMEF14 FBLIM1 | 2.30e-11 | 63 | 142 | 8 | 1p36.21 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p36 | PRAMEF7 PRAMEF12 PRAMEF8 PRAMEF1 PRAMEF2 NPHP4 PRAMEF13 PRAMEF14 FBLIM1 MUL1 | 5.55e-05 | 681 | 142 | 10 | chr1p36 |
| Cytoband | 7p21.3 | 8.97e-05 | 28 | 142 | 3 | 7p21.3 | |
| GeneFamily | PRAME family | 4.72e-11 | 24 | 102 | 7 | 686 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 3.10e-08 | 57 | 102 | 7 | 1179 | |
| GeneFamily | Complement system|Sushi domain containing | 1.70e-06 | 36 | 102 | 5 | 492 | |
| GeneFamily | ADAM metallopeptidases with thrombospondin type 1 motif | 1.58e-04 | 19 | 102 | 3 | 50 | |
| GeneFamily | Latent transforming growth factor beta binding proteins | 1.88e-04 | 4 | 102 | 2 | 628 | |
| GeneFamily | Glutamate metabotropic receptors|Protein phosphatase 1 regulatory subunits | 8.63e-04 | 8 | 102 | 2 | 281 | |
| GeneFamily | PDZ domain containing|Crumbs complex | 1.11e-03 | 9 | 102 | 2 | 1223 | |
| GeneFamily | PHD finger proteins | 1.68e-03 | 90 | 102 | 4 | 88 | |
| GeneFamily | Aminoacyl tRNA synthetases, Class II | 5.06e-03 | 19 | 102 | 2 | 132 | |
| GeneFamily | PWWP domain containing | 6.76e-03 | 22 | 102 | 2 | 1147 | |
| Coexpression | MORI_SMALL_PRE_BII_LYMPHOCYTE_UP | PRAMEF7 PRAMEF12 PRAMEF8 PRAMEF1 PRAMEF2 PRAMEF13 PSME4 PRAMEF14 EPHA3 | 3.06e-09 | 98 | 141 | 9 | MM592 |
| Coexpression | KINNEY_DNMT1_METHYLATION_TARGETS | 2.59e-08 | 34 | 141 | 6 | MM955 | |
| Coexpression | HUANG_GATA2_TARGETS_DN | PRAMEF7 SIAH1 PRAMEF12 PRAMEF8 PRAMEF1 PRAMEF2 PRAMEF13 PRAMEF14 | 6.01e-08 | 98 | 141 | 8 | MM942 |
| Coexpression | KOHOUTEK_CCNT2_TARGETS | 2.80e-07 | 81 | 141 | 7 | MM938 | |
| Coexpression | BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_TRANS | PRAMEF7 PRAMEF12 PRAMEF8 PRAMEF1 PRAMEF2 PRAMEF13 MAP1S EPOP PRAMEF14 | 5.98e-07 | 180 | 141 | 9 | MM612 |
| Coexpression | MEISSNER_BRAIN_HCP_WITH_H3_UNMETHYLATED | 6.31e-07 | 57 | 141 | 6 | MM1262 | |
| Coexpression | INGRAM_SHH_TARGETS_UP | PRAMEF7 PRAMEF12 PRAMEF8 PRAMEF1 PRAMEF2 PRAMEF13 TRIM10 PRAMEF14 | 2.13e-06 | 156 | 141 | 8 | MM550 |
| Coexpression | YAMAZAKI_TCEB3_TARGETS_DN | PRAMEF7 PRAMEF12 PRAMEF8 PRAMEF1 PRAMEF2 PRAMEF13 FZD5 PRAMEF14 LTBP4 | 4.85e-06 | 232 | 141 | 9 | MM1019 |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 9.51e-06 | 191 | 141 | 8 | MM17059 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 1.15e-05 | 196 | 141 | 8 | M3008 | |
| Coexpression | DESCARTES_ORGANOGENESIS_SCHWANN_CELL_PRECURSOR | 1.53e-05 | 98 | 141 | 6 | MM3656 | |
| Coexpression | NABA_CORE_MATRISOME | 1.64e-05 | 270 | 141 | 9 | MM17057 | |
| Coexpression | NABA_CORE_MATRISOME | 1.89e-05 | 275 | 141 | 9 | M5884 | |
| Coexpression | SANSOM_APC_TARGETS | PRAMEF7 PRAMEF12 DCLRE1B PRAMEF8 PRAMEF1 PRAMEF2 PRAMEF13 PRAMEF14 | 5.65e-05 | 245 | 141 | 8 | MM735 |
| Coexpression | HALLMARK_COMPLEMENT | 1.08e-04 | 200 | 141 | 7 | M5921 | |
| Coexpression | NABA_MATRISOME | SFTA3 COL13A1 ADAMTS3 KCP RSPO4 ADAMTSL3 VWDE CCN5 CILP2 SRPX2 ADAMTS9 ADAMTS17 CHRD LTBP2 LTBP4 KNG1 | 1.33e-04 | 1026 | 141 | 16 | M5889 |
| Coexpression | LI_PBMC_MENACTRA_AGE_18_45YO_ANTI_DT_ANTIBODY_CORRELATION_PROFILE_3DY_DN | 1.39e-04 | 19 | 141 | 3 | M40932 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Mesenchymal-stromal_related|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.36e-08 | 195 | 142 | 9 | 1be9502577267ca2a04656a99d57e3e2f124d92e | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.42e-08 | 196 | 142 | 9 | 9737a5f006d37b549f281e1863aca558e1e4dc99 | |
| ToppCell | distal-mesenchymal-Alveolar_Fibroblast-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.63e-08 | 199 | 142 | 9 | 28c1722deef3b8347371c7359be7c64b95780de3 | |
| ToppCell | distal-1-mesenchymal-Myofibroblast|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.63e-08 | 199 | 142 | 9 | 58c36f5a30c6862b7f5587a0b9bc31da99e43dd5 | |
| ToppCell | medial-mesenchymal-Alveolar_Fibroblast|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.70e-08 | 200 | 142 | 9 | c22cbfecee00183dd4be678f116ab9fd9ad0a4dd | |
| ToppCell | distal-2-mesenchymal-Alveolar_Fibroblast|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.70e-08 | 200 | 142 | 9 | 12b705dabec1b3752a488a891eda1a5123fcdc41 | |
| ToppCell | medial-2-mesenchymal-Alveolar_Fibroblast|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.70e-08 | 200 | 142 | 9 | cc6062dac07916c29091fc6bee2b864d29e6525b | |
| ToppCell | medial-mesenchymal-Alveolar_Fibroblast-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.70e-08 | 200 | 142 | 9 | 5c0716bf375c8158f7dc2c82bf5eaf37af594dd0 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-PMP-PMP_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.68e-08 | 170 | 142 | 8 | b1a16600754e0c12f7d39c9221f1b03135833f16 | |
| ToppCell | COPD-Epithelial-Mesothelial|World / Disease state, Lineage and Cell class | 1.47e-07 | 185 | 142 | 8 | 23579988036fc1925992c31919750f9b3fe9f790 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Mesenchymal-stromal_related-FDC|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.12e-07 | 194 | 142 | 8 | f9fbb043411546d8c9e0321a64165d411f44aeb7 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.20e-07 | 195 | 142 | 8 | df409f94f4e83be89f7a608058ee07ce3ce3a149 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.20e-07 | 195 | 142 | 8 | 4243190ad291d56694e2155954dbaa879c9d3844 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.29e-07 | 196 | 142 | 8 | 42e9828222a9663525d571633e8a454c30bfa7f8 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.29e-07 | 196 | 142 | 8 | cecf82cd5e0a3835d655f5e7478578674a63ce25 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.38e-07 | 197 | 142 | 8 | 13896ec65ccda0b928c91d41112dc01b480036b7 | |
| ToppCell | Adult-Mesenchymal|Adult / Lineage, Cell type, age group and donor | 2.47e-07 | 198 | 142 | 8 | 26e55b409db2a1637c95fae7c54b0abea1ef550c | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.47e-07 | 198 | 142 | 8 | f1374f7a50244d59c766ac41f44c08c9117407d2 | |
| ToppCell | Biopsy_Control_(H.)-Mesenchymal-Myofibroblasts|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 2.57e-07 | 199 | 142 | 8 | 7a227c239afdaebcac84644d9b2653a5f1a4be71 | |
| ToppCell | distal-mesenchymal-Myofibroblast-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.57e-07 | 199 | 142 | 8 | 79917b5225cb45b4a0ea937f79f1752346e4346e | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.57e-07 | 199 | 142 | 8 | 66a79732caf2f04c09b4d9832377aa01ca477677 | |
| ToppCell | Bronchial-10x5prime-Stromal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.67e-07 | 200 | 142 | 8 | 5ea12e17f50fefbf5534e487af3392b2fa2d13ad | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 2.67e-07 | 200 | 142 | 8 | aa1a35dcca3b799241eef4237f6eb94660e019f0 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.67e-07 | 200 | 142 | 8 | a510deaada669e690329183e18df02870bd204b3 | |
| ToppCell | Bronchial-10x5prime-Stromal-Fibroblastic-Fibro_adventitial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.67e-07 | 200 | 142 | 8 | b04831708fa20471a127b87e8db3728b6e729ce8 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Peri/Epineurial_|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.67e-07 | 200 | 142 | 8 | 4c3c11dd5e71ebc3d62264eeaeb71a850b149779 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.67e-07 | 200 | 142 | 8 | dd4228cbed8a4395166a6332e08d44d88bebe3b9 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-B_(AT2)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 6.94e-07 | 97 | 142 | 6 | eab10b1af9cd0ce373cd4d0316e0d7b218630584 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-B_(AT2)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 6.94e-07 | 97 | 142 | 6 | 04f571708f2487b0dbd70ee507de6bf75be5f5d9 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-G|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.16e-06 | 168 | 142 | 7 | 8c95093b1ea45826f62893edd3c410fe53b563a4 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-G-|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.16e-06 | 168 | 142 | 7 | b8c65542a0701ae31f49d332d87a64578e24b4e3 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.77e-06 | 179 | 142 | 7 | dcd0a83f0592ae27f814d064b4791f84c3c86e64 | |
| ToppCell | IPF-Epithelial-Mesothelial|IPF / Disease state, Lineage and Cell class | 1.84e-06 | 180 | 142 | 7 | 1fa54bf4dba72866b2295639d991af639341bc08 | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.06e-06 | 183 | 142 | 7 | 2beb5414958d38a5341870d55229f3b1707e76bf | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D122|Adult / Lineage, Cell type, age group and donor | 2.13e-06 | 184 | 142 | 7 | 2b7e6f91e11c228f0521e099886867d9e998e78d | |
| ToppCell | droplet-Lung-LUNG-30m-Mesenchymal|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.37e-06 | 187 | 142 | 7 | 976b74d081b7fba8620768613cc26f9262cd7b16 | |
| ToppCell | Control-Fibroblasts-Adventitial_FB|Control / group, cell type (main and fine annotations) | 2.46e-06 | 188 | 142 | 7 | 706a26c372add839d947749f0521a0e1f5c9b0ec | |
| ToppCell | COPD-Epithelial-Mesothelial|COPD / Disease state, Lineage and Cell class | 2.55e-06 | 189 | 142 | 7 | 79bb2593ad5d17f94b17972884241f03a0f43770 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.73e-06 | 191 | 142 | 7 | b7a57691a4742070cee640e285c1f4d0da95baf1 | |
| ToppCell | LV-02._Fibroblast_II|World / Chamber and Cluster_Paper | 2.73e-06 | 191 | 142 | 7 | d36565257ccba8c1bbed2c1c01be66a9cbb5f834 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.82e-06 | 192 | 142 | 7 | bc84b9ce01b4d826a682842ab8a395dac9b91183 | |
| ToppCell | IPF-Endothelial-VE_Arterial|Endothelial / Disease state, Lineage and Cell class | 2.82e-06 | 192 | 142 | 7 | e911e286da26202853f9650ba3cdefe5a5c9b585 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L4_RORB_BHLHE22|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.82e-06 | 192 | 142 | 7 | 25460ca9ebd3d49f666394cf99ab77a5e8f77250 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.82e-06 | 192 | 142 | 7 | 0ab1176cfbb0de8dd1f22c6e2c41265cf6c10ee1 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.92e-06 | 193 | 142 | 7 | 7cd9671e0ac64f7f3607f564485c63abbb7e7a63 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.02e-06 | 194 | 142 | 7 | c49f72441b3557e2c3a9c4239e68c0cf0652814b | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.02e-06 | 194 | 142 | 7 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 | |
| ToppCell | IPF-Stromal-Pericyte|World / Disease state, Lineage and Cell class | 3.02e-06 | 194 | 142 | 7 | 1a41da29d5adaf766a84eff0003b959e4523f7f1 | |
| ToppCell | ASK428-Mesenchymal|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.13e-06 | 195 | 142 | 7 | 2b156163975d9a3d3fda1402acd9831d0fdc9e25 | |
| ToppCell | COVID-19-Heart-Fib_1|Heart / Disease (COVID-19 only), tissue and cell type | 3.13e-06 | 195 | 142 | 7 | f423baa36ac7cdc383c033e35a7d17e6bf913323 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.13e-06 | 195 | 142 | 7 | cad6563cc51d212554152c727fc2c249c6a07e4d | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.13e-06 | 195 | 142 | 7 | 3c3703f092b6fc1b7333426fb5e2823bfb74bb57 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.13e-06 | 195 | 142 | 7 | 783bfa8110161cbd6def50ce849cae676c39c458 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.13e-06 | 195 | 142 | 7 | 47762d9e442fb1f6f0033e3e10f4c6e498d2c081 | |
| ToppCell | ASK428-Mesenchymal-Fibroblast|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.13e-06 | 195 | 142 | 7 | c269c0d894a0f55da6495b59d4b9abb9f68df684 | |
| ToppCell | IPF-Stromal-Pericyte|IPF / Disease state, Lineage and Cell class | 3.24e-06 | 196 | 142 | 7 | 8b6ff47ce5291d223f5e639fc45cd9267f418256 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.24e-06 | 196 | 142 | 7 | 7d8505dac15fa59935ccf592afc54b04c4c6554f | |
| ToppCell | 368C-Fibroblasts-Fibroblast-G|368C / Donor, Lineage, Cell class and subclass (all cells) | 3.35e-06 | 197 | 142 | 7 | 156155c2f0c1a2461e45803da578af18ee221660 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.35e-06 | 197 | 142 | 7 | 09946ee8dfb15a2a32da06e5b331f3277ee934f4 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.35e-06 | 197 | 142 | 7 | 94a9603cbd3516fbcce871909693b88f20d41713 | |
| ToppCell | normal_Lung-Fibroblasts-COL13A1+_matrix_FBs|normal_Lung / Location, Cell class and cell subclass | 3.35e-06 | 197 | 142 | 7 | 6c57ab2efb8363828e24211c4d45e58bb73a9a4d | |
| ToppCell | 368C-Fibroblasts-Fibroblast-G-|368C / Donor, Lineage, Cell class and subclass (all cells) | 3.35e-06 | 197 | 142 | 7 | d5d9263451f6c10cb3b9c17740183ca334e24851 | |
| ToppCell | distal-mesenchymal-Alveolar_Fibroblast-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.46e-06 | 198 | 142 | 7 | 7f728ca6d5317890c6fcde3ce6c10c0970d49a05 | |
| ToppCell | COPD-Stromal-Fibroblast|World / Disease state, Lineage and Cell class | 3.46e-06 | 198 | 142 | 7 | 2f13c0b3372af53d1bd85f9546f315c878580a71 | |
| ToppCell | distal-mesenchymal-Adventitial_Fibroblast-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.46e-06 | 198 | 142 | 7 | bfd720e2dae3b6b3dc2bf8b2096c554fd456e756 | |
| ToppCell | proximal-mesenchymal-Alveolar_Fibroblast|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.58e-06 | 199 | 142 | 7 | 7f4840ae6a888380feca722543e5e52783f3e35d | |
| ToppCell | proximal-3-mesenchymal-Alveolar_Fibroblast|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.58e-06 | 199 | 142 | 7 | 301d02bbb37e6f1d24b6e865bc3fe3e91260eb30 | |
| ToppCell | proximal-mesenchymal-Alveolar_Fibroblast-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.58e-06 | 199 | 142 | 7 | 9a16e519fb0651a7c4d8e05b931df4fb3b0eb3d1 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Myofibroblastic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.58e-06 | 199 | 142 | 7 | 20f760d92c351a1dac4cc0a424c443ea03a179fe | |
| ToppCell | (5)_Fibroblast-G|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 3.58e-06 | 199 | 142 | 7 | b4a737575be9f8c65771832dd8cd25328d5dae0d | |
| ToppCell | distal-2-mesenchymal-Adventitial_Fibroblast|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.58e-06 | 199 | 142 | 7 | 97b475f9110ef7bb29d9cf2109b7e43177830f05 | |
| ToppCell | Bronchial-10x5prime-Stromal-Fibroblastic-Fibro_peribronchial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.58e-06 | 199 | 142 | 7 | e1f1950d6f840485e263b83dc81b98910be3ae7a | |
| ToppCell | distal-mesenchymal-Alveolar_Fibroblast-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.58e-06 | 199 | 142 | 7 | fb23ecce41e31e2cc01814e3c0add756f489561f | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.58e-06 | 199 | 142 | 7 | 0019cfaa586a450c2e4952d1184a540561c8d0ba | |
| ToppCell | Parenchymal-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.58e-06 | 199 | 142 | 7 | 7c272a1aa7f3e931ad5d20809719d85b3bce4cb0 | |
| ToppCell | distal-mesenchymal-Alveolar_Fibroblast|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.58e-06 | 199 | 142 | 7 | 655d07cf9a2fd9b945a2ed4f824cba0297de72a8 | |
| ToppCell | Biopsy_Other_PF-Mesenchymal-Myofibroblasts|Biopsy_Other_PF / Sample group, Lineage and Cell type | 3.70e-06 | 200 | 142 | 7 | e504570fd7eec1524c401b1cfa9d10822d80d994 | |
| ToppCell | medial-2-mesenchymal|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.70e-06 | 200 | 142 | 7 | a9d8aa5bcf383d98a9e2eaf4b1f8466982d6b088 | |
| ToppCell | Biopsy_Control_(H.)-Mesenchymal-Fibroblasts|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 3.70e-06 | 200 | 142 | 7 | 8d75ce89393df452defacf2ec9a5bd4b7708afbb | |
| ToppCell | Parenchymal-10x5prime-Stromal-Peri/Epineurial_-NAF_epineurial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.70e-06 | 200 | 142 | 7 | 36de49593cf6ff1c9229fcceb150c1d68658a360 | |
| ToppCell | Tracheal-10x5prime-Stromal-Fibroblastic-Fibro_peribronchial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.70e-06 | 200 | 142 | 7 | 8ab0051544ea32eb8b3f7f8ba7582deaf8bf26c0 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Fibroblastic-Fibro_alveolar|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 3.70e-06 | 200 | 142 | 7 | 750ff51c9de08aecec230f4a402e0bf5a789f24c | |
| ToppCell | Parenchymal-10x5prime-Stromal-Myofibroblastic-Muscle_perivascular_immune_recruiting|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.70e-06 | 200 | 142 | 7 | 38190e4b32f7469df1da7d130bca6d7b12a3dd06 | |
| ToppCell | Biopsy_IPF-Mesenchymal-Fibroblasts|Biopsy_IPF / Sample group, Lineage and Cell type | 3.70e-06 | 200 | 142 | 7 | d8637f1e62d3fb9476dc51e1b1dc2f4b14b5fcd8 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_adventitial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.70e-06 | 200 | 142 | 7 | 6b48ddde83bc6c941d557844aa214d4d2c8e736d | |
| ToppCell | medial-mesenchymal|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.70e-06 | 200 | 142 | 7 | 4f19e1e40966e27779bf77e8c170ed3ecc24353e | |
| ToppCell | Parenchymal-10x5prime-Stromal-Peri/Epineurial_-NAF_endoneurial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.70e-06 | 200 | 142 | 7 | 8a4c210a3130f7baedf15ecbc0f4903b97da0352 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-3|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.70e-06 | 200 | 142 | 7 | 07641f476cb1a131c2a50258b88cc13bb38c8379 | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-3|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 3.70e-06 | 200 | 142 | 7 | 343fa6ba1f52d816d2e41466f674ff8360aecd81 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.70e-06 | 200 | 142 | 7 | 74e74123ea7bf38d337a3a0248a6a51437c6ab42 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-3-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.70e-06 | 200 | 142 | 7 | d0c00cdd52c2e001aec9b935f4e981ba77d0386a | |
| ToppCell | distal-3-mesenchymal-Alveolar_Fibroblast|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.70e-06 | 200 | 142 | 7 | 20112be28f80baffad92641c9cfd7c3718967dbb | |
| ToppCell | droplet-Heart-HEART_(ALL_4:4:4:1:1)-30m-Mesenchymal-fibroblast|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.42e-06 | 138 | 142 | 6 | e2659949944bdf39b23c7275e380a7a937e2726c | |
| ToppCell | droplet-Heart-HEART_(ALL_4:4:4:1:1)-30m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.42e-06 | 138 | 142 | 6 | d5342383c5e52b92c39d7afe76560501be3ea5cd | |
| ToppCell | E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal-matrix_-_immature_3|E16.5-samps / Age Group, Lineage, Cell class and subclass | 8.42e-06 | 149 | 142 | 6 | 651494e84be03dc7b061ebdfa91756a1c507b9b4 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.72e-05 | 169 | 142 | 6 | 47fd4adfe54777e69a0fabf8bd34f26223f63275 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.72e-05 | 169 | 142 | 6 | e09259d62cd3e42f0919f231ed1164db59b0b6c3 | |
| ToppCell | ASK440-Epithelial-Transformed_epithelium|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.90e-05 | 172 | 142 | 6 | df3800bcd9777d02900eba0cfc26ab73de8a1d95 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.17e-05 | 176 | 142 | 6 | cb8fd56a4f935cdda19d7ab43382cdda7c307667 | |
| ToppCell | 356C-Lymphocytic-NK_cells-NK_cell_A2|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.17e-05 | 176 | 142 | 6 | 052b54c4337ca728974a106b6dbd3b72dd28eb23 | |
| Disease | Ehlers-Danlos Syndrome, Type VIII | 1.93e-05 | 2 | 130 | 2 | C0268347 | |
| Disease | synaptotagmin-5 measurement | 1.93e-05 | 2 | 130 | 2 | EFO_0803120 | |
| Disease | autosomal recessive nonsyndromic deafness 16 (implicated_via_orthology) | 1.93e-05 | 2 | 130 | 2 | DOID:0110471 (implicated_via_orthology) | |
| Disease | Ehlers-Danlos syndrome, periodontitis type | 1.93e-05 | 2 | 130 | 2 | cv:C0268347 | |
| Disease | coronary artery disease | NPC1 THSD7A ADAMTS3 DCLRE1B APOH VWDE SIRT3 MAP1S ATXN8OS ZNF335 SIK2 C1R C1S C2 SMAD9 WDR72 | 7.46e-05 | 1194 | 130 | 16 | EFO_0001645 |
| Disease | cystatin C measurement | 7.64e-05 | 402 | 130 | 9 | EFO_0004617 | |
| Disease | Weill-Marchesani syndrome | 1.15e-04 | 4 | 130 | 2 | cv:C0265313 | |
| Disease | Malaria, Falciparum | 1.15e-04 | 4 | 130 | 2 | C0024535 | |
| Disease | Weill-Marchesani syndrome (is_implicated_in) | 1.15e-04 | 4 | 130 | 2 | DOID:0050475 (is_implicated_in) | |
| Disease | prolyl 4-hydroxylase subunit alpha-2 measurement | 1.15e-04 | 4 | 130 | 2 | EFO_0802918 | |
| Disease | partial thromboplastin time | 1.58e-04 | 24 | 130 | 3 | EFO_0004310 | |
| Disease | complement C4b measurement | 1.79e-04 | 25 | 130 | 3 | EFO_0008092 | |
| Disease | galectin-1 measurement | 1.91e-04 | 5 | 130 | 2 | EFO_0020932 | |
| Disease | dynactin subunit 2 measurement | 2.86e-04 | 6 | 130 | 2 | EFO_0020338 | |
| Disease | amyloid beta A4 precursor protein-binding family B member 2 measurement | 2.86e-04 | 6 | 130 | 2 | EFO_0801379 | |
| Disease | complement C1q subcomponent measurement | 2.86e-04 | 6 | 130 | 2 | EFO_0008089 | |
| Disease | blood sedimentation | 3.99e-04 | 7 | 130 | 2 | EFO_0004304 | |
| Disease | Nephronophthisis, familial juvenile | 3.99e-04 | 7 | 130 | 2 | C1855681 | |
| Disease | clusterin measurement | 3.99e-04 | 7 | 130 | 2 | EFO_0007655 | |
| Disease | complement C1r subcomponent measurement | 3.99e-04 | 7 | 130 | 2 | EFO_0008090 | |
| Disease | nephrolithiasis | 4.14e-04 | 33 | 130 | 3 | EFO_0004253 | |
| Disease | Complement deficiency disease | 4.14e-04 | 33 | 130 | 3 | C0272242 | |
| Disease | osteosarcoma | 5.30e-04 | 8 | 130 | 2 | EFO_0000637 | |
| Disease | interleukin-21 measurement | 5.30e-04 | 8 | 130 | 2 | EFO_0801724 | |
| Disease | hematocrit | TRIM46 SPRY3 BRPF3 TRIM26 ACO1 TMPRSS6 CHAF1A DGKD CR1 MAST2 RGS14 FZD5 LTBP4 | 5.39e-04 | 1011 | 130 | 13 | EFO_0004348 |
| Disease | aspartate aminotransferase measurement | TRIM46 CACNA1S PDE3A THSD7A DENND2D THSD7B APOH ZAP70 CILP2 ADAMTS9 OSBPL5 NPAS2 | 6.72e-04 | 904 | 130 | 12 | EFO_0004736 |
| Disease | Dermatitis, Irritant | 6.80e-04 | 9 | 130 | 2 | C0162823 | |
| Disease | BMI-adjusted waist-hip ratio, adult onset asthma | 6.80e-04 | 9 | 130 | 2 | EFO_0007788, EFO_1002011 | |
| Disease | tyrosine-protein phosphatase non-receptor type 4 measurement | 6.80e-04 | 9 | 130 | 2 | EFO_0802172 | |
| Disease | afamin measurement | 6.80e-04 | 9 | 130 | 2 | EFO_0008015 | |
| Disease | response to topoisomerase inhibitor, response to antineoplastic agent | 6.80e-04 | 9 | 130 | 2 | GO_0072758, GO_0097327 | |
| Disease | Neoplasm Recurrence, Local | 6.80e-04 | 39 | 130 | 3 | C0027643 | |
| Disease | cigarettes per day measurement | 7.43e-04 | 438 | 130 | 8 | EFO_0006525 | |
| Disease | adseverin measurement | 8.47e-04 | 10 | 130 | 2 | EFO_0801358 | |
| Disease | Mouth Diseases | 1.24e-03 | 12 | 130 | 2 | C0026636 | |
| Disease | C-X-C motif chemokine 10 measurement | 1.40e-03 | 109 | 130 | 4 | EFO_0008056 | |
| Disease | creatinine measurement | TRIM46 CACNA1S CHAF1B MAST2 JAG2 RGS14 CILP2 PTPN9 FAM47E KNG1 SHISA3 WDR72 | 1.53e-03 | 995 | 130 | 12 | EFO_0004518 |
| Disease | open-angle glaucoma | 1.61e-03 | 191 | 130 | 5 | EFO_0004190 | |
| Disease | urate measurement, bone density | 1.73e-03 | 619 | 130 | 9 | EFO_0003923, EFO_0004531 | |
| Disease | adult onset asthma | 1.87e-03 | 118 | 130 | 4 | EFO_1002011 | |
| Disease | interleukin 18 receptor 1 measurement | 1.95e-03 | 15 | 130 | 2 | EFO_0008178 | |
| Disease | Seasonal Affective Disorder | 2.22e-03 | 16 | 130 | 2 | C0085159 | |
| Disease | eosinophil count | CHAF1B TRIM26 BACH2 KCP IER5 APOH ZAP70 RGS14 CILP2 SIK2 C1S LTBP2 LTF SPIDR LTBP4 | 2.36e-03 | 1488 | 130 | 15 | EFO_0004842 |
| Disease | urolithiasis | 2.74e-03 | 63 | 130 | 3 | MONDO_0024647 | |
| Disease | renal system measurement | 3.47e-03 | 20 | 130 | 2 | EFO_0004742 | |
| Disease | bilirubin measurement | 3.52e-03 | 442 | 130 | 7 | EFO_0004570 | |
| Disease | renal cell carcinoma (is_implicated_in) | 3.54e-03 | 69 | 130 | 3 | DOID:4450 (is_implicated_in) | |
| Disease | Lupus Erythematosus, Systemic | 3.84e-03 | 71 | 130 | 3 | C0024141 | |
| Disease | carotid artery intima media thickness | 3.88e-03 | 450 | 130 | 7 | EFO_0007117 | |
| Disease | obesity (biomarker_via_orthology) | 4.13e-03 | 147 | 130 | 4 | DOID:9970 (biomarker_via_orthology) | |
| Disease | Attention Deficit Disorder | 4.20e-03 | 22 | 130 | 2 | C0041671 | |
| Disease | Minimal Brain Dysfunction | 4.20e-03 | 22 | 130 | 2 | C1321905 | |
| Disease | tooth agenesis | 4.20e-03 | 22 | 130 | 2 | EFO_0005410 | |
| Disease | juvenile idiopathic arthritis | 4.31e-03 | 74 | 130 | 3 | EFO_0002609 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PKLPQVGLSRPSCCL | 51 | Q75L30 | |
| VVPCCSGPKRPQDKV | 366 | P21399 | |
| CKLPASPRRVSRCSP | 21 | Q8NAP1 | |
| KDPPFCVARCPSGVK | 591 | P04626 | |
| APPTRTPSAKRCILC | 16 | P59051 | |
| PNTSCPVPIKVCPRS | 496 | Q9BYV9 | |
| KLPECREVKCPFPSR | 196 | P02749 | |
| ESGELVCTKPIPCQP | 481 | Q86V21 | |
| VAKAPVPCSGPGRVR | 86 | O14514 | |
| PRSICSLPCQPGERK | 516 | Q14833 | |
| LPCPGKATLAVRCCP | 281 | Q13112 | |
| QSPSRPVDCILCPNK | 261 | Q9ULD4 | |
| KGAPPCPSRRCAAVA | 4511 | Q96M86 | |
| SCPELTSGPRMCPRK | 206 | Q13111 | |
| RCSRPQKVCLCPFLP | 71 | Q8NBA8 | |
| RCLPVCGKPVNPVEQ | 446 | P00736 | |
| PCQVVPIVSRRPCGG | 291 | Q9H816 | |
| VCENLPCPKGLPSFR | 591 | Q8TE56 | |
| RSKGQCPEPPIVVHC | 501 | P43378 | |
| CSVKSPQGCVVERPP | 1746 | Q8WYB5 | |
| TLSRPCRVPLGKEVC | 211 | Q99743 | |
| KVVRVLFPGCTPPAC | 426 | Q66K74 | |
| TVPCGRERTTRPPKC | 536 | Q6ZNB6 | |
| RPPKCKEQCSRPPTC | 546 | Q6ZNB6 | |
| PTKCPVPVCRGRSFT | 261 | Q9UJA3 | |
| DQGCQPTPRFCRKPI | 56 | Q6A163 | |
| GPRCRLPVPSKECSL | 1126 | Q5IJ48 | |
| LEKAPGQCLRPPCEA | 931 | Q9Y219 | |
| LGPQCSKLPLPSCCR | 61 | P0DMR3 | |
| KAVCKPVRCPAPVSF | 81 | P06681 | |
| KKFPCTRPPCTGVVD | 171 | Q96KN9 | |
| TVAAPRPVCQRCGQP | 41 | Q9BRP1 | |
| RGCPTTPKSPKCRAE | 2011 | O15018 | |
| PQILTPPVICSSCGR | 576 | Q14432 | |
| ACEPSLPSPKVRRLC | 611 | P35663 | |
| CLKPPKTRRVSSLCP | 411 | Q8NA70 | |
| VRLPSRCEPPGTTCT | 131 | P49862 | |
| PEPKKCPICRQAITR | 331 | Q969V5 | |
| CRFCSVKTARNPPPL | 141 | O43766 | |
| TVCKRCVEPGPARPQ | 161 | Q1L5Z9 | |
| LCPACSVPPRLVSAV | 371 | P21917 | |
| PCEQKVRGCSTLPPS | 831 | O75161 | |
| CVRCRPLTPEGKQRP | 976 | O15118 | |
| DCCQRAPPTPRKVGR | 476 | Q8WUB8 | |
| PKIIVFSTVPCPRCG | 446 | O95522 | |
| PLPPCRSVCERAKAG | 101 | Q13467 | |
| GPFVCKCREPFVPIL | 186 | Q13467 | |
| ALRPCPGASQPCILE | 351 | O43603 | |
| GEKPESVRACQLPPC | 1001 | O15072 | |
| PRPVAKEECSVTPCG | 1226 | Q9P2N4 | |
| PKVPADEVCGCPLVR | 556 | Q9P0U4 | |
| ETCPPRTFLPALCKI | 46 | Q9ULT8 | |
| KPVDGSCCQPRPPVT | 296 | Q96PB1 | |
| PPPRCISTNKCTAPE | 1581 | P17927 | |
| QPCRVLGPHSKPCVE | 1706 | Q13698 | |
| CSPTPRKPCRGTQEF | 21 | A6NHQ4 | |
| LPRTAPCISESPRKC | 421 | Q86XJ1 | |
| CKRKSCRNPPDPVNG | 91 | Q2VPA4 | |
| PVCDRIICGLPPTIA | 151 | Q2VPA4 | |
| CVPVCGVPREPFEEK | 421 | P09871 | |
| PHPRRVEVLGKCCPE | 146 | O76076 | |
| ASLCPCPSVKFRPGL | 11 | Q96PT4 | |
| KQCEPCSPNVRFLPR | 371 | P29320 | |
| KCPLPGTEAFREICP | 711 | Q14767 | |
| LGLRARPPQKCSTPC | 116 | Q8TF76 | |
| DVPCRGCPLTQKSEP | 1756 | Q6P0Q8 | |
| PGVPSRPASVAVCRC | 41 | Q8N2S1 | |
| DCPQRCRSLGPKPVS | 101 | Q6ZST2 | |
| CPLGLCKVSVIPPTA | 286 | Q16760 | |
| PVCSICENPIIPRDG | 301 | Q8WUP2 | |
| REIPASVCTLPCKPG | 516 | Q14831 | |
| ARRVPVPSCCVPTSS | 206 | P60413 | |
| VPVSFKPAVCVPVRC | 36 | P59990 | |
| RGPKCRIEISSPCCP | 321 | Q5T749 | |
| FVQPPTKICVGCPRD | 256 | P01042 | |
| RRREAPKTSPGCNCP | 106 | Q5TAT6 | |
| RGLRPEVICPCASSP | 656 | Q14689 | |
| SLKRCCVLGLPPTSP | 61 | Q8NBF1 | |
| VNTPGERSFLCKCPP | 86 | P82279 | |
| KSPVRCAGVNPVPCN | 496 | Q3B820 | |
| PKIIVFCTVPCPRCG | 446 | Q5VWM4 | |
| PGPRLPKVYCIISCI | 146 | Q9H6A0 | |
| PQPCATACKPVIRVP | 406 | O76013 | |
| QPKRIFIGPTPCPSC | 446 | Q5VWM6 | |
| DFVPGGESPCPRCRK | 796 | Q9H0X9 | |
| PPAVCPRKRCAAGVG | 211 | Q5VY09 | |
| CSEPGECPAKKRPRL | 291 | Q2TAK8 | |
| RKGCPPCTGLVTQVP | 56 | Q6ZV65 | |
| KPPPLEATKGCTECR | 176 | Q7Z4K8 | |
| PPRVACVQVVIIPCG | 1296 | P07814 | |
| ESRKCPIQRPCPGER | 186 | Q2I0M5 | |
| PPVSCIKRDSPIQCI | 51 | P02788 | |
| KCPESLRPETVRPCL | 751 | Q9UPZ6 | |
| LSSPVPAVCRKEPCV | 16 | O75792 | |
| ICVAKAVECPPPRTT | 426 | Q15046 | |
| TICALICGRPIVKPE | 161 | O60934 | |
| QPKRIFIGPTPCPSC | 446 | Q5SWL7 | |
| QVSCVRLQCPPLPCK | 931 | Q6ZWJ8 | |
| PRDTPPKCIRCAVVG | 141 | Q9UJ37 | |
| CLLDPVPPVLVRKGC | 426 | Q9H0K1 | |
| RPKLTCCPTCRGPLG | 66 | Q8IUQ4 | |
| CTCLRPKEPSQQPIR | 121 | A0PJX4 | |
| RVPRCPVCTGVVKPD | 276 | Q9NTG7 | |
| VLCRKEPAPPPGVCT | 876 | Q5T8A7 | |
| QPKRIFIGPTPCPSC | 446 | O95521 | |
| QPKRIFIGPTPCPSC | 446 | O60811 | |
| VPTRPSPGAIQSRCC | 331 | Q8NFA2 | |
| VKRLCAGLLPPPTSC | 441 | Q7RTU9 | |
| GRCKCVPCTAARPLP | 151 | O43610 | |
| CPGQPSKCVTIPRSL | 61 | O15198 | |
| CPGRPLEAQKCVRPR | 181 | Q8IUL8 | |
| ASRVLCSRPVCDPPG | 156 | O43916 | |
| RTNKVICSPPLCPGA | 196 | Q9NS84 | |
| RVSCKNIKPECPTPA | 96 | Q9H2X0 | |
| PLREDPKTPLTCGCA | 196 | Q8WW14 | |
| PKTPLTCGCAQRPSI | 201 | Q8WW14 | |
| PKIIVFCTVPCPRCG | 446 | Q5VXH5 | |
| EGDKNPTSPCLICRP | 1066 | Q8N2E2 | |
| PTSPCLICRPKISRF | 1071 | Q8N2E2 | |
| CNLRKPCNRPSGLEP | 96 | P43403 | |
| KPCQASPPRLGVCAR | 1041 | Q96KV7 | |
| VPRIPCARKPFICEE | 151 | P17023 | |
| KVTSCPGCRKPLPRC | 771 | Q9NXC5 | |
| PSCVHPIIKRRQCRP | 226 | Q9UMS5 | |
| KPCPPGERKARDCTV | 61 | P25445 | |
| KTCEVYCPDIPLPRR | 396 | Q14159 | |
| CVDIDPPKIRCPHSR | 176 | O60687 | |
| QLRCIPCKGSRFPPT | 686 | O75717 | |
| VAPRSPKRPFQCSVC | 371 | Q8NBB4 | |
| PQKTNPCEICGPVLR | 86 | Q9Y2P7 | |
| RIERPCCSPKYGSPK | 1191 | O94964 | |
| PLPCPGLQVESSCKV | 641 | Q3MJ13 | |
| EVRERPCPHPGCNKV | 461 | Q8N554 | |
| KARDKSPCRSQGCPP | 451 | O43566 | |
| SPCRSQGCPPRTQDK | 456 | O43566 | |
| ISGSRPVCPLCKKPF | 46 | Q12899 | |
| PCEISGCPKPTQIIA | 1226 | Q14997 | |
| GPEKTCPSRPSCLEK | 471 | Q92543 | |
| CRTLASRGTPPCKPS | 36 | Q96JL9 | |
| CPGSKESSPRPQCVI | 756 | O95789 | |
| TCPLCKEPFRPGSFR | 56 | Q9UDY6 | |
| LPQRVSVFKCPSCPL | 851 | Q8N1G0 | |
| KRIPTCVAVCVPSPG | 51 | P0C7M3 | |
| VKRLCAGLLPPPTSC | 441 | A6NGW2 | |
| STRPETVRPCFLPCK | 721 | Q9C0I4 | |
| RPAAIRQCIPACRKP | 1466 | Q9C0I4 | |
| VCPLCNVPVPVARGE | 56 | Q8WV99 | |
| TPKLSSFPCPVCGRV | 556 | Q9H4Z2 | |
| HCVACGLLRTPRPKP | 31 | Q96RJ3 | |
| ATTPCGKVPICIPAR | 251 | Q04725 | |
| PVCVPARDQRAPRKC | 111 | Q6ZVH6 | |
| RSCVKKPNPQCDGRP | 541 | Q8IU80 | |
| GPKLPTERPCLLEAC | 611 | P82987 | |
| FKCKPGDPSRRPCLI | 441 | Q96S06 | |
| SCTPQEGGCPRPKER | 186 | Q86VE0 |